Signs and symptoms
Genes
Methods
Disclaimer
About us
Publications
Contact us
Patients
Users
Database
Login
Overview of included studies for DYT/PARK-GCH1:
Click here for summary of patients' characteristics
Click here for summary of genetic findings
Click here to show world map of all countries
Filter for
all included patients
index patients only
AAO < 50 (adjustable)
AAO >= 50 (adjustable)
females only
males only
homozygous only
heterozygous only
compound heterozygous only
homozygous and compound heterozygous
carrying
definitely pathogenic mutations
probably pathogenic mutations
possibly pathogenic mutations
-22C>T
c.(343+1_344-1)_(2000_?)del
c.(343+1_344-1)_(453+1_454-1)del
c.(343+1_344-1)_(453+1_454-1)dup
c.(343+1_344-1)_(509+1_510-1)del
c.(453+1_454-1)_(2000_?)del
c.(453+1_454-1)_(509+1_510-1)del
c.(453+1_454-1)_(541+1_542-1)del
c.(453+1_454-1)_(626+1_627-1)del
c.(509+1_510-1)_(2000_?)del
c.(541+1_542-1)_(2000_?)del
c.(541+1_542-1)_(626+1_627-1)del
c.(626+1_627-1)_(2000_?)del
c.(?_-163-1)_(2000_?)del
c.(?_-163-1)_(343+1_344-1)del
c.(?_-163-1)_(509+1_510-1)del
c.(?_-163-1)_(541+1_542-1)del
c.-189-44_-189-62delTGACGCGAGGCGGGGCCG
c.119dupC
c.141_142delGC
c.142C>T
c.159delG
c.166G>T
c.170G>A
c.172-175delCCCC
c.175C>G
c.181G>T
c.193G>T
c.193delG
c.1A>G
c.1A>T
c.206C>T
c.209delA
c.218C>A
c.221C>A
c.224A>C
c.224A>G
c.227C>A
c.228delG
c.229_246delCCATCCTGAGCTCGCTG
c.22_23GC>TA
c.230C>G
c.233delT
c.235_240delCTGAGC
c.241T>C
c.242C>A
c.245T>C
c.248G>C
c.250G>T
c.262C>G
c.263G > T
c.263G>A
c.265C>T
c.267_284delAGGGCTGCTCAAGACGCC
c.269G>T
c.271C>G
c.272T>G
c.281C>A
c.281C>T
c.283C > T
c.284C>G
c.284C>T
c.287G>A
c.292G>A
c.293C>T
c.295G>C
c.2T>C
c.308A>C
c.309G>C
c.309delG
c.312C>A
c.313_315dupTTC
c.317C>T
c.320_329delAGGGCTACCA
c.323G>A
c.328C>G
c.328C>T
c.329dupA
c.339C>G
c.341C>A
c.341C>G
c.343+1G>T
c.343G>A
c.344+5G>C
c.344-2A>G
c.350T>G
c.353delA
c.358G>T
c.3G>C
c.400delG
c.401A>G
c.404T>A
c.404T>C
c.409A>G
c.410T>G
c.410_446delTGTTTTCCATGTGTGAGCATCACTTGGTTCCATTTGT
c.431A>C
c.435G>T
c.440C>A
c.453+1G>A
c.453+1G>C
c.453+3A>T
c.453+6G>T
c.454-2A>G
c.455T>A
c.458A>G
c.461T>G
c.463G>A
c.470T>C
c.488T>G
c.509+1G>A
c.509+2T>C
c.509+2dupT
c.509+5G>A
c.524A>G
c.532_534delAGA
c.536_538delTAC
c.539A>C
c.541+1G>A
c.541+1G>C
c.541G>A
c.544C>G
c.544C>T
c.547G>A
c.54C>A
c.550C>T
c.551G>A
c.554T>G
c.557C>A
c.557C>T
c.562C>T
c.568delG
c.571G>A
c.578T>A
c.592C>T
c.595C> G
c.595C>T
c.5A>G
c.601G>A
c.607G>A
c.608G>A
c.610G>A
c.611T>G
c.612_617delAGTGGT
c.614T> G
c.617T>C
c.618_626+6del
c.61_62delGGinsAACC
c.623C>A
c.625A>C
c.626+1G>A
c.626+1G>C
c.626+1G>T
c.626+2T>G
c.626+2dupT
c.626+3_626+6delAAGT
c.626C>T
c.627-2dupA
c.628delC
c.629A>G
c.630C>G
c.631A>G
c.631_632delAT
c.633G>A
c.635_636delGT
c.646C>T
c.650G>T
c.653dupT
c.656A>C
c.662T>G
c.669C>A
c.670A>G
c.670A>T
c.671A > G
c.671A>G
c.676_677insA
c.679A>G
c.689_690delTG
c.690G>A
c.695G>A
c.695G>T
c.695Gdel
c.703C>G
c.703C>T
c.706G>T
c.706delG
c.721C>T
c.722G>A
c.726_727insTTCCC
c.745delA
c.747G>C
c.751T>C
Country
Australia
Belgium
Brazil
Canada
China
Colombia
Denmark
Estonia
France
Germany
India
Italy
Japan
Pakistan
Poland
Portugal
Serbia
South Africa
South Korea
Spain
Switzerland
Taiwan
United Kingdom
United States
Study
Study design
N cases
Ethnicities
Sex
(%
♂
)
Mean AAO (+/- SD)
Reported mutations
Wassenberg, 2020
Case report/Case series
4
n.a.
25%
7(+/-5)
c.454-2A>G
: het
p.Glu65Serfs*2
: het
p.Met211Valfs*38
: het
Chen, 2020
Case report/Case series
2
n.a.
50%
4(+/-2)
p.Met211Valfs*38
: het
Wang, 2020
Case report/Case series
1
n.a.
100%
3
c.(?_-163-1)_(343+1_344-1)del
: het
Shin, 2020
Case report/Case series
1
A
0%
47
p.Ala74Asp
: het
Ahn, 2019
Case report/Case series
10
A
20%
10(+/-6)
p.Arg216*
: het
p.Val204Ile
: het
p.Ala98Thr
: het
c.453+3A>T
: het
p.Thr186Ile
: het
c.509+2T>C
: het
c.627-2dupA
: het
p.Val226Aspfs*24
: het
p.Ala74Asp
: het
p.Ala208Glu
: het
Show more (+7)
Giri, 2019
Family study
2
I
100%
3(+/-2)
p.Val204Ile
+
p.Arg184His
: comp. het.
p.Arg184His
: het
Gowda, 2019
Case report/Case series
1
n.a.
n.a.
0
p.Arg235Gly
: hom
Rudakou, 2019
Mutational screen
4
n.a.
75%
58(+/-7)
p.Lys224Arg
: het
p.Arg184Cys
: het
p.Met221Thr
: het
Yoshino, 2018
Case report/Case series
14
A
7%
24(+/-20)
p.Glu61*
: het
c.509+2dupT
: het
c.626+1G>C
: het
p.Cys18*
: het
c.626+2T>G
: het
c.626+2dupT
: het
p.Thr209Ile
: het
p.Arg216*
: het
p.Gln182*
: het
p.Thr186Lys
: het
c.343+1G>T
: het
Show more (+8)
Ma, 2018
Mutational screen
2
A
0%
5(+/-2)
p.Thr106Ile
: het
p.Gly203Glu
: het
1
2
3
4
5
6
7
8
9
10
…
Next ›
Last page »
Show all studies on one page
© University of Lübeck. Last updated on
Dec. 2, 2020. Version: 3.5.95
MDSGene works best with JavaScript enabled. Please follow
these instructions
to activate JavaScript in your web browser.
MDSGene works best with JavaScript enabled. Please follow
these instructions
to activate JavaScript in your web browser.